Risk of ovarian cance very low among older women with stable adnexal masses on ultrasound, finds study

The detection of adnexal masses in older patients often raises concerns about ovarian cancer, which poses a common clinical challenge for gynecologists. While surgical evaluation is the only way to immediately rule out cancer, subjecting all patients to surgery would cause excessive harm because the vast majority of these masses are benign. Recent study aimed to assess the ovarian cancer risk among older patients with stable adnexal masses on ultrasound. It was a retrospective cohort study conducted on patients aged 50 years and older with an adnexal mass of less than 10 cm on ultrasound between 2016 and 2020 in a large community-based health system. The masses were considered stable if they did not exhibit an increase of more than 1 cm in the greatest dimension or a change in standardized reported ultrasound characteristics. The study included 4061 patients with stable masses, with an average age of 61 years and an initial mass size of 3.8 cm. Among these patients, 11 cancers were detected, resulting in an absolute risk of 0.27%. The study found that ovarian cancer risk declined with longer duration of stability, with no cancer cases observed after 52 weeks of stability. The risk of ovarian cancer was 0.73 per 1000 person-years at 6 to 12 weeks of stability, 0.63 at 13 to 24 weeks, 0.44 at 25 to 52 weeks, and 0.00 at over 52 weeks. The study suggested that ongoing ultrasound imaging would be needed for 369 patients at 6 to 12 weeks of stability, 410 patients at 13 to 24 weeks, 583 patients at 25 to 52 weeks, and over 1142 patients with stable masses at 53 to 104 weeks to detect one case of ovarian cancer. The authors concluded that the risk of ovarian cancer was very low among older women with stable masses on ultrasound. They recommended that the benefit of ultrasound monitoring beyond 12 months is minimal and may be outweighed by potential risks of repeated imaging.

Discussion

The study found that among patients aged 50 years and older with stable adnexal masses on ultrasound, the risk of ovarian cancer was low and declined with longer demonstrated stability. The researchers suggested that ultrasound monitoring of stable masses beyond 12 months is of minimal benefit and might be associated with potential risks of repeated imaging. These findings indicate that the duration of ultrasound monitoring for stable masses should be limited, considering the minimal benefit and potential risks associated with prolonged surveillance.

Conclusion

In conclusion, the study provides important insights into the ovarian cancer risk among older patients with stable adnexal masses and suggests that prolonged ultrasound monitoring may not be necessary for patients with stable masses. The researchers highlight the importance of considering the potential risks of repeated imaging when determining the optimal duration of ultrasound monitoring for stable adnexal masses.

Key Points

1. The study aimed to assess the ovarian cancer risk among older patients with stable adnexal masses on ultrasound. It was a retrospective cohort study conducted on patients aged 50 years and older with an adnexal mass of less than 10 cm on ultrasound between 2016 and 2020 in a large community-based health system. The masses were considered stable if they did not exhibit an increase of more than 1 cm in the greatest dimension or a change in standardized reported ultrasound characteristics.

2. The study included 4061 patients with stable masses, with an average age of 61 years and an initial mass size of 3.8 cm. Among these patients, 11 cancers were detected, resulting in an absolute risk of 0.27%. The study found that ovarian cancer risk declined with longer duration of stability, with no cancer cases observed after 52 weeks of stability. The risk of ovarian cancer was 0.73 per 1000 person-years at 6 to 12 weeks of stability, 0.63 at 13 to 24 weeks, 0.44 at 25 to 52 weeks, and 0.00 at over 52 weeks.

3. The study suggested that ongoing ultrasound imaging would be needed for 369 patients at 6 to 12 weeks of stability, 410 patients at 13 to 24 weeks, 583 patients at 25 to 52 weeks, and over 1142 patients with stable masses at 53 to 104 weeks to detect one case of ovarian cancer.

4. The authors concluded that the risk of ovarian cancer was very low among older women with stable masses on ultrasound. They recommended that the benefit of ultrasound monitoring beyond 12 months is minimal and may be outweighed by potential risks of repeated imaging.

5. The study found that among patients aged 50 years and older with stable adnexal masses on ultrasound, the risk of ovarian cancer was low and declined with longer demonstrated stability. The researchers suggested that ultrasound monitoring of stable masses beyond 12 months is of minimal benefit and might be associated with potential risks of repeated imaging.

6. In conclusion, the study provides important insights into the ovarian cancer risk among older patients with stable adnexal masses and suggests that prolonged ultrasound monitoring may not be necessary for patients with stable masses. The researchers highlight the importance of considering the potential risks of repeated imaging when determining the optimal duration of ultrasound monitoring for stable adnexal masses.

Reference –

Suh-Burgmann EJ, Hung YY, Schmittdiel JA. Ovarian cancer risk among older patients with stable adnexal masses. Am J Obstet Gynecol 2024;231:440.e1-7.

Powered by WPeMatico

Novel Pulmonary Valve Aims to Reduce Invasive Surgeries for Kids, finds study

One of the longstanding challenges of pediatric pulmonary valve replacement is size and the ability to accommodate growth. Young children tend to quickly outgrow fixed size valves-leading to the need for multiple invasive surgeries throughout childhood.

Now, an investigational clinical trial at Children’s Hospital Los Angeles is testing a potential solution to this problem: a novel pulmonary valve that can be size-adjusted as a child grows.

The investigational device, called the Autus Size-Adjustable Valve, is designed to be balloon-expanded-via minimally invasive catheterization procedures-as a child grows. Last year, Children’s Hospital Los Angeles became the first center on the West Coast to offer this trial, which has now expanded to 10 sites around the country.

“Currently, pediatric valvular lesions are essentially a lifelong disease,” says Luke Wiggins, MD, a congenital cardiothoracic surgeon in the Heart Institute at CHLA and the site principal investigator for the study, which also involves Darren Berman, MD. “This new technology has the potential to revolutionize the way we approach and manage these patients.”

How the valve works

The Autus Valve, which is made by Autus Valve Technologies Inc., is a fully synthetic pulmonary valve that is surgically implanted in pediatric patients. Its design mimics the geometry of the human venous valve and features two leaflets.

Because the implant diameter is customizable, surgeons can implant the valve at the size appropriate for the child. The valve is designed to function across a wide range of diameters-from 12.7 to 22 millimeters.

That’s important because while some current pulmonary valves can be balloon-dilated in a catheterization lab to open stenotic leaflets as a child grows, this can often cause the valve to leak.

“One of the unique aspects of the Autus Valve is its two-leaflet design,” Dr. Wiggins explains. “That helps accentuate coaptation of the leaflets. So, when the valve is later balloon-dilated in the Cath lab, it can maintain its competency as a one-way valve.”

Children’s Hospital Los Angeles has been part of the study since its early feasibility phase. The valve is now being studied in a Food and Drug Administration pivotal trial.

The prospective, single-arm, multicenter study plans to enroll 50 patients, ages 18 months to 16 years, who require surgical pulmonary valve replacement. CHLA has so far implanted the device in three patients.

The next frontier

Although the Autus Valve aims to address the major issues of size and growth accommodation in pediatric pulmonary valve replacement, additional challenges remain.

“There is still a lot of opportunity for improvement in pulmonary valve prostheses,” Dr. Wiggins says. “For example, many existing prosthetic heart valves require anti-coagulation, which can cause side effects in children. And many of the biologic valves in use today break down quickly because of kids’ heightened immune responses.

“I see improving these pulmonary valves as the next frontier for our field,” he adds. “This trial is an exciting step toward that future, but there is more ground to cover.”

Dr. Wiggins notes that these trials are only possible because of the multidisciplinary care at the Heart Institute-the largest heart program for children in the Western United States.

“Although the surgical team places the valve, we work very closely with our pediatric cardiologists, our echocardiography and imaging specialists, and our interventional congenital cardiologists in the Catheterization Lab,” he says. “It’s that seamless teamwork that allows us to optimize care for these patients.”

Powered by WPeMatico

UP DGME Releases Schedule For Round 1 NEET PG Counselling 2024

Uttar Pradesh: The Directorate General of Medical Education (UP DGME) released the Round 1 NEET PG 2024 counselling schedule for PG medical admissions in the state this year.

All the concerned candidates seeking to appear in the state’s NEET PG counselling are advised to take note of the information released by the UPDGME as follows:

The time table of online NEET PG counseling for the first round for admission to postgraduate courses (MD/MS/Diploma and DNB) in Government/Autonomous/private medical colleges/institutes/ universities/hospitals under medical Health is as follows:-

S.No

Description

Dates

Total Days

Date of Online Choice
Filling

18th November
2024 (From 5:00 PM) to 25th November 2024 (Till 11:00 AM)

07
days

Date
of Declaration of result of seat allotment

27th November
2024

01
days

Date
for downloading allotment letters and admission process

28th November to 30th November 2024

and
02nd December to 04th December 2024

06
days

• Only candidates registered under UP NEET PG- 2024 can participate in the counseling process.

• Only those registered candidates who have deposited the registration fee and security amount will be eligible for choice filling.

• Candidates should assess their eligibility themselves as per the provisions contained in the Government Order No. 1/687326/2024 dated 09 July 2024 regarding UP NEET PG 2024 policy and the brochure of UP NEET PG-2024.

MCC had earlier released the counselling schedule for states. As per the schedule released by MCC, the state counselling authorities will begin the counselling on November 18 2024 after the sharing of joined cnaiddtaes date by the MCC on 28th to 29th November.

Rest of the state counselling schedule is as follows:

NEET PG State Counselling Schedule

S.No.

Schedule for Admission

State Counselling

All India Quota/

Deemed &Central Universities

Sharing of

Joined candidates

Data by MCC

Sharing of Joined candidates Data by state DMEs/ State Counselling Authorities*

1

Ist Round of Counselling

20th Sept., 2024 to 20th Nov., 2024

28th Nov., 2024 to 29th Nov., 2024

18th Nov., 2024 to 27th Nov., 2024

5th Dec., 2024 to 6th Dec., 2024

2

Last date of Joining

27th Nov., 2024

_

4th Dec., 2024

_

3

2nd round of Counselling

4th Dec., 2024 to 12th Dec., 2024

21st Dec., 2024. to 22nd Dec., 2024

12th Dec., 2024 to 23rd Dec., 2024

29th Dec., 2024 to 31st Dec., 2024

4

Last date of joining

20th Dec., 2024

_

28th Dec., 2024

_

5

Round-3

26th Dec., 2024 to 1st Jan., 2025

14th Jan., 2025 to 15th Jan., 2025

7th Jan., 2025 to 13th Jan, 2025

19th Jan., 2025 to 20th Jan., 2025

6

Last date of joining

13th Jan., 2025

_

18th Jan., 2025

_

Stray Vacancy

18th Jan., 2025 to 24th Jan., 2025

31st Jan., 2025

25th Jan., 2025 to 30th Jan., 2025

_

Last date of joining

30th Jan., 2025

5th Feb., 2025

Commencement of Academic Session for PG Courses

20th December, 2024

To view the official Notice, Click here :  https://medicaldialogues.in/pdf_upload/up-neet-pg-time-schedule-for-md-ms-dimploma-dnb-260096.pdf

Powered by WPeMatico

Indira Gandhi ESI Hospital Delhi Vacancies: Walk In Interview For SR, Super Specialist Post, All Details Here

New Delhi: The Indira Gandhi Employees State Insurance Hospital (IG ESI Hospital Jhilmil) has announced vacancies for the Senior Resident, Super Specialist posts in different departments in this medical institute.

ESI is a statutory body constituted under an Act of Parliament (ESI Act, 1948) and works under the administrative control of the Ministry of Labour and Employment, Government of India.

ESIC Vacancy Details:-

Total no of Vacancies: 31

Senior Resident:- 25

The Vacancies are in the Departments of – Orthopedics, Ophthalmologist, Dermatology, Gynaecology, Pulmonologist, Psychiatry, Anesthesia, Surgery, ENT, and General Medicine.

Super Specialist:- 06

The Vacancies are in the Departments of Cardiology, Endocrinology, Gastroenterology, Nephrology, Neurology, and Urology.

The date of walk In Interview is 11th and 12th November 2024.

Venue and Reporting Time: The office of the Medical Superintendent, IG ESI Hospital, Jhilmil, New Delhi- 110095 At 9.00 AM.

For more details about Qualifications, Age, Pay Allowance, and much more, click on the given link:
https://medicaljob.in/jobs.php?post_type=&job_tags=ESIC+DElhi&location=&job_sector=all

What are the Instructions for Eligible Candidates:-

Applicants are advised to reach the office of the Medical Superintendent, IG ESI Hospital, Delhi on the date of walk-ininterview i.e. on 11.11.2024 and 12.11.2024 at 9.00 A.M. as per scheduled interview mentioned in the advertisement along with original documents and one set of photocopies (self-attested) aslisted on the application form. No candidate will be entertained after 10.30 A.M.

The candidates must bring original documents for verification at 9.00 AM Sharp on the date of interview.

The candidates are advised to bring their all Original Certificates with one set of self-attested photocopies of the following documents during verification: –

1. Identity proof [PAN Card, Passport, Driving License, Voter Card, Aadhar Card etc.]

2. Address Proof [Ration Card, Passport, Driving License, Aadhar Card etc.]

3. Certificate showing date of birth [10th certificate/Birth certificate]

4. Two recent passport size photographs

5. Photocopies of Aadhar/PAN Card and Bank Passbook [At the time of joining for only selected candidates]

6. Class 10th/12th mark sheets and certificates 7. MBBS, MD/MS/DNB/DM and Experience certificates whichever is applicable as per NMC guidelines.

8. Registration with Medical Council of India/State Medical Council [For Medical Candidates]

9. Internship completion certificate.

10. Reservation category certificate [OBC/SC/ST/PH/EWS] in the format prescribed by Govt. of India.

11. NOC certificate from present employer if applicable

12. Experience certificate if applicable.

13. Income and Asset certificate from issuing Authority as per DOPT letter no. 36039/1/2019. Esst. (Res) dated 31st January 2019 must be submitted for the reservation for EWS Category.

Also Read:Applications Open: 77 JR Post In Various Departments At AIIMS Delhi, Check Details Here

Powered by WPeMatico

High-speed 3D bioprinter can fabricate structures that closely mimic diverse tissues in human body

Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissue to harder materials like cartilage and bone.

Powered by WPeMatico

Researchers develop promising new genetic breast cancer model

A Michigan State University researcher’s new model for studying breast cancer could help scientists better understand why and where cancer metastasizes.

Powered by WPeMatico

Heat, air pollution, disease: How climate change affects health

Record-breaking heat, extreme weather events, air pollution and the spread of infectious disease: climate change poses an already vast yet rising threat to the health of humans around the world, experts warn.

Powered by WPeMatico

Altogether 8672 MBBS Seats added to 72 new, 30 Existing Medical Colleges, NMC Gives Break Up

New Delhi: Altogether 8672 MBBS Seats have been added to the seat matrix of the country for the academic year 2024-2025, as per the recent National Medical Commission (NMC) notification.

As per the break-up of the seats added during this academic year, 6850 MBBS seats have been added to 72 New Medical Colleges and intake capacity of MBBS seats has been increased by 1822 MBBS seats at 30 existing medical colleges.

Sharing the details of the medical colleges (both existing and newly set up institutes along with their intake capacity), NMC wrote to the Principal/Dean of all the medical colleges/institutes in India, NMC, “Please find enclosed the details of Increase in intake of MBBS seats in existing medical colleges and List of MBBS seats of the newly established medical colleges for the AY 2024-25 issued by the Medical Assessment and Rating Board (MARB). All concerned medical colleges and health institutions are requested to kindly take note of the same.”

Also Read: NMC Increases MBBS Seats at 2 Rajasthan-based Medical Colleges After HC Order

Increased Intake of MBBS Seats in Existing Medical Colleges for the Academic Year 2024-2025: 

NMC has shared the data of MBBS seats increased at the existing medical colleges for the academic year 2024-2025 including the name of the State, name of the medical college, name of the district, University name, management of the college, year of inception of the college, annual intake of seats, status of NMC recognition, and date of LOP.

As per NMC data, 30 existing medical colleges now have an intake capacity of 6075 MBBS seats with an increase of 1822 MBBS seats for 2024-2025.

According to the data, shared by NMC, 50 MBBS seats have been increased at medical colleges including GMC Ananthapuram, Konaseema Institute of Medical Sciences and Research Foundation, Rajiv gandhi Institute of Medical Sciences, Tomo Riba Institute of Health and Medical Sciences, Mata Gujri Memorial Medical College, Lord Buddha Koshi Medical College and Hospital, A J Institute of Medical Sciences and Research Centre, Kanachur Institute of Medical Sciences, MVJ Medical College and Research Hospital, Mysore Medical College and Research Institute, Sri Devaraj URS Medical College, Srinivas Institute of Medical Research Centre, Oxford Medical College Hospital & Research Centre, Pacific Institute of Medical Sciences, Agartala Government Medical College, K D Medical College Hospital and Research Centre, LLRM Medical College, Meerut, Gouri Devi Institute of Medical Sciences and Hospital, IQ-City Medical College, KPC Medical College, Jadavpur, Kolkata.

Further, 100 MBBS seats have been increased at medical institutes including Varun Arjun Medical College (UP), T S Misra Medical College and Hospital, Lucknow, G.S Medical College and Hospital, Hapur, Jaipur National University Institute of Medical Sciences and Research Centre, Jagatpura, KMCT Medical College Kozhikode, Kempegowda Institute of Medical Sciences, Bangalore, and Viswabharathi Medical College (Andhra Pradesh).

Apart from these, 72 MBBS seats have been added to S N Medical College, Agra, 20 MBBS seats have been increased at Goa Medical College Panaji, 30 seats at Indira Gandhi Institute of Medical Sciences, Patna.

MBBS seats of the newly established medical colleges for 2024-2025: 

The data shared by NMC revealed that for the academic year 2024-2025, altogether 6850 MBBS seats have been added to 72 new medical colleges.

Among these, 100 MBBS seats are available at medical colleges including Tinsukia Medical College (Assam), Himalaya Medical College and Hospital (Bihar), Abhishek Mishra Memorial Medical College (Chhattisgarh), Bhagyodyay Medical College (Gujarat), PES University Institute of Medical Sciences and Research (Karnataka), SR Patil Medical College and Hospital (Karnataka), GMC Seoni (Madhya Pradesh), School of Medical Sciences, Sri Satya Sai University of Technology and Medical Sciences (MP), Sundarlal Patwa Govt Medical College (MP), Virendra Kumar Sakhlecha GMC (MP), GMC Ambernath (Maharashtra), GMC Amravati (Maharashtra), GMC Bhandara (Maharashtra), GMC Buldhana (Maharashtra), GMC Gadchiroli (Maha), GMC Hingoli (Maha), GMC Jalna (Maha), GMC Washim (Maha), GMC Banswara (Rajasthan), GMC Baran (Raj), GMC Jhunjhunu (Raj), GMC Nagaur (Raj), Sudha Medical College (Raj), Vyas Medical College and Hospital Jodhpur (Raj), GMC Sawai Madhopur (Raj), Annai Medical College sand Rajalakshmi Health City (Tamil Nadu), Kanyakumari Medical Mission Research Centre (TN), Autonomous State Medical College and Hospital (Uttar Pradesh), Autonomous State Medical College Sultanpur (UP), Autonomous State Medical College and Hospital Auraiya (UP), Autonomous State Medical College and Hospital Gonda (UP), Autonomous State Medical College Kushinagar (UP), Autonomous State Medical College Lalitpur (UP), Autonomous STate Medical College Pilibhit (UP), Autonomous State Medical College Akbarpur (UP), Autonomous State Medical College Sonebhadra (UP), Baba Kina Autonomous State Medical College and Hospital, Kalyan Singh GMC (UP), Mahatma Vidur Autonomous State Medical College (UP), Shri Gorakshnath Medical College Hospital (UP), GMC Haridwar (Uttarakhand), Krishnanagar Institute of Medical Sciences (West Bengal).

50 MBBS seats are available at East West Institute of Medical Sciences (W.B), Shri Siddhi Vinayak Medical College and Hospital Sambhal (UP), GMC Quthbullapur (Telangana), GMC Narsampet (Telangana), GMC Narayanpet (Telangana), GMC Mulugu (Telangana), GMC Maheshwaram (Telangana), GMC Jogulumba (Telangana), GMC Medak (Telangana), Autonomous State Medical College and Hospital Yadadri (Telangana), JIET Medical College and Hospital (Raj), RIMT Medical College and Hospital (Punjab), Government Medical College and Hospital Jajpur (Orissa), Shri Ramchandra Institute of Medical Sciences (Maha), Mahatma Gandhi Missions Medical College (Maha), GMC Nashik (Maharashtra), GMC L.T Marg (Maha), and GMC Paderu (Andhra Pradesh).

150 MBBS seats are available at Graphic Era Institute of Medical Sciences (Uttarakhand), Ajay Sangal Institute of Medical Sciences and Ayushman Hospital Shamli (UP), KMC Medical College and Hospital, Maharajganj (UP), Tripura Shantiniketan Medical College (Tripura), Nova Institute of Medical Sciences and Research Centre (Telangana), J R Medical College and Hospital Villupuram (TN), Institute of Medical Sciences and SUM Hospitals (Orissa), P A Sangama International Medical College and Hospital (Meghalaya), VN Public Health and Educational Trust (Kerala), BGS Medical College and Hospital (Karnataka), and Shri Rawatpura Institute of Medical Sciences (Chhattisgarh), 

To view the NMC data, click on the link below:

https://medicaldialogues.in/pdf_upload/nmc-mbbs-seats-matrix-260114.pdf

Also Read: NMC Approval to 44 new medical colleges, MBBS seats intake increase at 19 institutes

Powered by WPeMatico

KGMU to acquire New Vacuum Suction Machine to Boost Prosthetic Care

Lucknow: In a significant step to revolutionize prosthetics, the King George’s Medical University (KGMU), is set to acquire a vacuum suction machine designed to improve the fit and comfort of artificial prosthetic limbs. The new machine, which costs around 8-10 lakhs, will facilitate more precise production of prostheses.

This advanced technology is expected to reduce common issues such as air gaps, misalignment, and discomfort that are often seen in traditional prosthetic limbs.

Senior prosthetist and in-charge of the Prosthetic Orthotic Unit at KGMU’s Physical Medicine and Rehabilitation (PMR) Department, Shagun Singh, explained that the technology aims to reduce the sense of artificiality for recipients and provide a more natural experience. During World Prosthetic and Orthotic Day, Singh highlighted that traditional prosthetics, often manually crafted using moulding machines, can lead to issues such as air gaps and misalignment.

Also Read: Delhi AIIMS signs MoA with CAPFIMS, Cabinet nod to funding of Rs 2207.50 crore

”We aim to improve usability. The machine introduces the use of polypropylene, which is expected to replace heavier thermosetting plastics. This switch is intended to make prostheses lighter,” Singh added.\

Currently, KGMU which produces 12-15 new artificial limbs every month also repairs approximately a dozen more. The institution also manufactures 250-300 assistive devices for people with partial limb functionality annually.

Also Read: Affordable lower limb prosthetic systems to be available soon

As per the recent media report by TOI, “An artificial hand costs around Rs 4,000 at KGMU, in contrast to approximately Rs 25,000 at private facilities, illustrating the institution’s commitment to affordability. With the acquisition of this new machine, KGMU aims to increase its output and provide more lightweight, accurately fitted prosthetic options,” Singh said.

Dr Shakuntala Misra organized an awareness rally to highlight the importance of accessible and advanced technology in prosthetics and orthotics. The rally, held at Rehabilitation University, KGMU, and Ram Manohar Lohia Institute of Medical Sciences, was organized to mark International Prosthetic and Orthotic Day.

The rally began at the 1090 intersection at 7 am and concluded at 9 am. The rally was attended by at least 100 participants including prosthetic and orthotic specialists like VK Singh, Shagun Singh, Ranjit Kumar, Dharmveer Kumar, and Sant Prakash Gautam.

VK Singh stated that the event underscored the importance of accessible and advanced prosthetic and orthotic technology in enhancing the quality of life for individuals relying on artificial aids.

Powered by WPeMatico

Cannot expect media to verify every advertisement! HC Denies to Impose Ban on Doctors, Hospitals from Advertising

Chennai: The Madras High Court recently refused to impose any ban on doctors and hospitals from advertising in the media, One India has reported.

Although the Public Interest Litigation (PIL) was filed before the HC bench seeking to impose a ban on the media from publishing advertisements promoting fake doctors, fake drugs, and medical treatments and hospitals, the HC bench comprising Chief Justice Sriram, Senthil Kumar Ramamurthy observed that it cannot be expected from the media to verify every advertisement related to doctors and hospitals.

Filing the PIL, the petitioner sought regularization of advertisements related to doctors and hospitals in newspapers, television, and media. It was argued by the petitioner that doctors and hospital-related advertisements were misleading the public.

Also Read: Tamil Nadu Doctors’ Association demands strict action against Misleading Ads by Patanjali

The petitioner further pointed out that people were being made to believe by giving exaggerated and fake advertisements regarding medical treatments. Therefore, the plea sought a ban on the media from publishing advertisements promoting fake doctors, drugs, and medical treatments and hospitals.

As per the latest media report by Tamil One India, the HC bench observed that it could not be expected that the media should check and publish every advertisement related to doctors and hospitals. It noted that the Medical Commission could take action against doctors and hospitals who violated the rules.

The judges further noted that the petitioner could file a complaint in this regard with the Medical Commission and if fake hospitals and doctors publish such advertisements, they could also file complaints before police.

Since there are already laws to take action against objectionable advertisements, the HC bench refused and ordered to dismiss the case noting that they could not issue a general order to take action against the media publishing the advertisements. 

Also Read: 38,539 misleading advertisements of Ayush drugs registered to State Licensing Authorities in last 3 years: AYUSH Ministry

Powered by WPeMatico